Another Successful Vesalio™ Clot Interaction Workshop in Barcelona
On January 22 and 23, a diverse group of physicians from 8 different countries trained on new approaches for clot…
Changing Outcomes CHANGING LIVES!
Designed for first pass success with all clot types in stroke thrombectomy
Currently not available in your region.
Innovation in progress
in development…
When complexity requires simplicity
in peripheral arterial occlusion
A specific design
A decisive solution
for post aSAH cerebal vasospasm
The next frontier in thrombectomy
designed to maximize clot retention
Currently not available in your region.
Choose to remove
large clot burden in coronary arterial occlusion
Currently not available in your region.
Innovation in progress
in development…
Designed for first pass success with all clot types in stroke thrombectomy
Currently not available in your region.
A specific design
A decisive solution
for post aSAH cerebal vasospasm
The next frontier in thrombectomy
designed to maximize clot retention
Currently not available in your region.
Innovation in progress
in development…
Designed for first pass success with all clot types in stroke thrombectomy
Innovation in progress
in development…
When complexity
requires simplicity
in peripheral arterial occlusion
Currently not available in your region.
A specific design
A decisive solution
for post aSAH cerebral vasospasm
This product is currently not available in your region
The next frontier in thromombectomy
designed to maximize clot retention
Choose to remove
large clot burden in coronary
arterial occlusion
Innovation in progress
in development…
Designed for first pass success with all clot types in stroke thrombectomy
A specific design
A decisive solution
for post aSAH cerebral vasospasm
This product is currently not available in your region
The next frontier in thromombectomy
designed to maximize clot retention
Occlusion of a brain artery
Strokes each year
Cause of severe disability
Cause of death worldwide
Due to clots
Occlusion of a heart artery
Heart attacks each year
Cause of death worldwide
Due to clots
Occlusion of an artery anywhere in the body
Acute limb ischemia each year
Will die at year one
Will need major amputation at year one
Due to clots
“Our experience with NeVa has been fantastic, with high complete recanalization rates as of the first attempt and we’re excited to be among the first centers to use the NeVa NET.”
NHS Royal London, London, UK
“enVast could provide a new therapeutic opportunity for myocardial infarct patients with large thrombus burden, who still represent a major challenge for procedural success and long-term outcomes.”
Istituto Cardiocentro Ticino, Lugano, Switzerland
“Patients with acute limb ischemia often present a complex medical history and pose significant challenges for physicians who must navigate severely diseased arteries and work within narrow, stenotic vessels. In such cases, when access is difficult, or when working below the knee, the low profile and excellent deliverability of pVasc make it an especially valuable tool.”
Sanger Heart and Vascular Institute, Charlotte, North Carolina.
“Complete angiographic resolution of vasospasm with one pass! It’s my new go-to device for symptomatic vasospasm.”
The Ohio State University Wexner Medical Center, Columbus, Ohio
Dr Fernando Ezequiel Petra, Mendoza, Argentina
Dr Dario Bongiovanni, Augsburg, Germany; Dr Francesco Loizzi, Bari, Italy; Dr Antonio Landi and Prof Marco Valgimigli, Lugano, Switzerland
On January 22 and 23, a diverse group of physicians from 8 different countries trained on new approaches for clot…
Vesalio reports it has surpassed 2,500 clinical cases with the NeVa™ neuro-thrombectomy platform. Physicians have evaluated the Neva Drop Zone™…
Vesalio announces it has successfully secured a Class A financing round. The proceeds will be utilized to support the ongoing…
Vesalio announced the start of enrollment in its NATURE study using enVast™, the company’s first thrombectomy system for patients presenting…
As an independent board chairman, Mike Kujak will bring expert knowledge and know-how from his years of leadership in the…
As a board observer and senior advisor to the company, Earl Slee brings extensive medical device innovation and business development…
On January 22 and 23, a diverse group of physicians from 8 different countries trained on new approaches for clot…
Vesalio reports it has surpassed 2,500 clinical cases with the NeVa™ neuro-thrombectomy platform. Physicians have evaluated the Neva Drop Zone™…
Vesalio announces another key milestone to support entry into the US neurovascular thrombectomy market. Enrollment has commenced in the Vesalio…
Vesalio announces it has successfully secured a Class A financing round. The proceeds will be utilized to support the ongoing…
Vesalio announced the start of enrollment in its NATURE study using enVast™, the company’s first thrombectomy system for patients presenting…
As an independent board chairman, Mike Kujak will bring expert knowledge and know-how from his years of leadership in the…
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
by removing vascular occlusions and restoring blood flow
Please select your region to enter our world of innovation:
"*" indicates required fields